 Home > Medical News > Latest Medical News > Simcere's CDK4/6 inhibitor Trirazil is planned to be included in the priority review

Simcere's CDK4/6 inhibitor Trirazil is planned to be included in the priority review

 Last Update: 2021-12-30
 Source: Internet
 Author: User

Tags

cell phone sticker

necrotic cell death

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On December 8, the latest announcement by the Center for Drug Evaluation (CDE) of the National Medical Products Administration of China showed that Jiangsu Simcere Pharmaceutical Co.

Screenshot source: CDE official website

The proposed indication for Trilaciclib injection is the prophylactic use of Trilaciclib in patients with extensive stage small cell lung cancer (ES-SCLC) receiving platinum-containing drugs combined with etoposide to reduce bone marrow suppression caused by chemotherapy The rate of occurrence

If approved, it will become the first CDK4/6 inhibitor with bone marrow-protecting efficacy approved for marketing in China

Trirazil is a First-in-Class therapy in the indications of myelosuppression caused by chemotherapy.

In August 2020, Simcere Pharmaceuticals introduced Trirazil from G1 Therapeutics for US$170 million, and the two parties reached an exclusive license agreement.

On November 29, 2021, Simcere Pharmaceuticals (2096.

Up to now, the 4 CDK4/6 inhibitors approved to be marketed globally are Pfizer’s pipercillil, Novartis’s Libecizil, Eli Lilly’s Abbezilil and G1’s Trirazilil

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.